A cross-sectional study was carried out in Kirkuk city from December 2016 to March 2017. The number of diabetic patients understudy were 180 whose ages were between 21-81 years old. These patients admitted to Kirkuk General Hospital and primary health care centers of Kirkuk first health care sector. The control group who were matched to the diabetic patients studied, included 90 healthy blood donors. Blood was collected for assessment of HbA1c test, blood glucose level, visfatin and chemerin levels. The study showed that the highest mean level of visfatin was found in diabetic patients comparing with healthy control ( 6.22±2.17 v.s. 3.54±1.91 ng/ml). The study showed that the highest mean level of chemerin was found in diabetic patients c...
Abstract To study the association and possible predictive role of visfatin, resistin, fetuin-A and c...
It is clear that sub-clinical inflammation is a key factor that triggers type 2 diabetes mellitus (T...
Background. Previous studies demonstrated that type 2 diabetes (T2D) patients have low serum magnesi...
IntroductionObesity is commonly associated with insulin resistance and hyperinsulinemia and is the m...
The aim of the present study is to evaluate vifatin levels in uncontrolled diabetic patients and unc...
The aim of the present study is to evaluate the levels of visfatin in sera of non-diabetic male with...
Background: Diabetes mellitus (DM) is one of the most common exocrine disorders affecting more than ...
The aims of the study to evaluate the association between diabetes mellitus and resistin, visfatin a...
Background: Adipose tissues produce adipocytokines and other various substances that have useful act...
Aim: To investigate circulating visfatin and vaspin levels in first-degree relatives of subjects wi...
BACKGROUND: Visfatin is an intracellular enzyme, known as nicotinamide phosphoribosyltransferase (Na...
Visfatin has shown to be increased in type 2 diabetes but to be unrelated to insulin sensitivity. We...
Prospective diabetes prevention studies can provide valuable information on the early pathogenesis o...
Aims: To investigate the relationship between dietary intake and biochemical parameters and anthropo...
Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that...
Abstract To study the association and possible predictive role of visfatin, resistin, fetuin-A and c...
It is clear that sub-clinical inflammation is a key factor that triggers type 2 diabetes mellitus (T...
Background. Previous studies demonstrated that type 2 diabetes (T2D) patients have low serum magnesi...
IntroductionObesity is commonly associated with insulin resistance and hyperinsulinemia and is the m...
The aim of the present study is to evaluate vifatin levels in uncontrolled diabetic patients and unc...
The aim of the present study is to evaluate the levels of visfatin in sera of non-diabetic male with...
Background: Diabetes mellitus (DM) is one of the most common exocrine disorders affecting more than ...
The aims of the study to evaluate the association between diabetes mellitus and resistin, visfatin a...
Background: Adipose tissues produce adipocytokines and other various substances that have useful act...
Aim: To investigate circulating visfatin and vaspin levels in first-degree relatives of subjects wi...
BACKGROUND: Visfatin is an intracellular enzyme, known as nicotinamide phosphoribosyltransferase (Na...
Visfatin has shown to be increased in type 2 diabetes but to be unrelated to insulin sensitivity. We...
Prospective diabetes prevention studies can provide valuable information on the early pathogenesis o...
Aims: To investigate the relationship between dietary intake and biochemical parameters and anthropo...
Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that...
Abstract To study the association and possible predictive role of visfatin, resistin, fetuin-A and c...
It is clear that sub-clinical inflammation is a key factor that triggers type 2 diabetes mellitus (T...
Background. Previous studies demonstrated that type 2 diabetes (T2D) patients have low serum magnesi...